Subsequent studies in bladder cancer lines expressing ERα showed that E2 induced cell proliferation (28, 39), while ER antagonists, including tamoxifen, raloxifene, and a pure anti-estrogen ICI 182,780, inhibited it (28, 39, 67). This evidence concerns the gene ESR1 and urinary bladder cancer.